Response Genetics' Q3 Revenues Climb on ResponseDx Uptick

Sales for the firm's ResponseDx pharmacogenomic tests more than doubled from the second quarter of 2009.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.